Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2 Negative Metastatic Breast Cancer
Interventions: DRUG: Cabazitaxel|DRUG: Paclitaxel
Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust